SCHEMBL4615403

SCHEMBL4615403

CCOC(=O)C1CCC=CCCCCCN(NC(=O)OC(C)(C)C)C(=O)C2CC(Oc3cc(-c4ccccc4)nc4cc(OC)ccc34)CC2C(=O)N1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TDP1 Q9NUW8 3/20 0.34
▸ TACR3 P29371 2/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ACACB O00763 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277219 0.89 CTSB (0.42) CTSBKDM4ESMN1; SMN2ALDH1A1MAPK1
SCHEMBL3039920 0.88 CTSB (0.61) CTSBKDM4ESMN1; SMN2ALDH1A1MAPK1
SCHEMBL3276524 0.88 CTSB (0.42) CTSBKDM4ESMN1; SMN2ALDH1A1MAPK1
SCHEMBL3050935 0.85 CTSB (0.63) CTSBKDM4ESMN1; SMN2ALDH1A1RAB9A
SCHEMBL3050936 0.85 CTSB (0.63) CTSBKDM4ESMN1; SMN2ALDH1A1RAB9A
SCHEMBL3049466 0.85 CTSB (0.49) CTSBKDM4ESMN1; SMN2ALDH1A1MAPK1
SCHEMBL3045951 0.83 CTSB (0.66) CTSBKDM4ESMN1; SMN2ALDH1A1RAB9A
SCHEMBL3045958 0.83 CTSB (0.66) CTSBKDM4ESMN1; SMN2ALDH1A1RAB9A
SCHEMBL3283641 0.82 CTSB (0.44) CTSBKDM4ESMN1; SMN2ALDH1A1RAB9A
SCHEMBL13248865 0.79 CTSB (0.82) CTSBKDM4ESMN1; SMN2ALDH1A1ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910347-A2 MACROCYLIC INHIBITORS OF HEPATITIS C VIRUS MEDIVIR AB (SE) 2008-04-16 — — EP disclosed
WO-2007017144-A2 MACROCYLIC INHIBITORS OF HEPATITIS C VIRUS MEDIVIR AB (SE) 2007-02-15 — — WO disclosed
Send feedback